In this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, explore with Erin K. McCreary, PharmD, and Atheendar S. Venkataramani, MD, PhD, how a large regional health system used a weighted lottery and intensive outreach to provide high-risk individuals in disadvantaged communities more equitable access to scarce monoclonal antibodies for preventing COVID-19. Related Content:
Association of New-Onset Seizures With SARS-CoV-2 Vaccines
Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy
February 2024 Medical News Summary
Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic
Safety and Effectiveness of Maternal and Child COVID-19 Vaccination
The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children
Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
How Safe Were Kids in School During Phases of the Pandemic?
Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination
Use of Mental Health Services During the COVID-19 Pandemic
Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults
Global COVID-19 Update
Receipt of Out-of-State Telemedicine Visits Among Medicare Beneficiaries During the COVID-19 Pandemic
Long COVID: The US Federal Response
Childcare Stress and Professional Outcomes Among US Health Care Workers During COVID-19
Global Association of COVID-19 Pandemic Measures With Cancer Screening
May 2022 Medical News Summary
Q&A With White House COVID-19 Response Coordinator Ashish Jha
Create your
podcast in
minutes
It is Free
JAMA Clinical Reviews
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews